Relisys Medical Devices Limited
16 products found

Relisys Medical Devices Limited products

RELISYS - Drug Eluting Stent Systems

RELISYS - Premier+ : Sirolimus Eluting Coronary Stent System

Highlighting Features: • Premier+ is an improved version of our first indigenously developed Sirolimus Eluting Coronary Stent System • Premier+ is with unique open and closed cell stent design on L 605 Cobalt Chromium stent platform with strut locking mechanism. This offers excellent radial strength and minimum recoil • The strut thickness for Premier+ is 63 μm • The delivery system in Premier+ is enhanced for its efficacy and deliverability and also displays the lowest entry profile • Hydrophilic Coated Stent Delivery System • Precise in Sirolimus Drug Release Kinetics • Completely biodegradable, biocompatible polymer (PLA carrier) – Loading dose density of 1.2 μg/mm² • 90% of Sirolimus is released within 90-120 days

RELISYS - Release-R : Sirolimus Eluting Coronary Stent System

Highlighting Features: • Release-R™ is the first indigenously developed Drug Eluting Stent in India • The strut thickness for Release-R™ is 65 μm • Unique open and closed cells Stent Design on L 605 Cobalt Chromium Stent platform with strut locking mechanism. This offers excellent radial strength and minimum recoil • Improved stent apposition and uniform neointimal coverage • Inhibits in-stent restenosis (ISR) and late thrombosis with adequate re-endothelialization • Completely biodegradable, biocompatible polymer (PLGA carrier) – Loading density of 1.2 +/-0.2 μg/mm² • 6 μm – Uniform coating thickness with precisely programmed release kinetics • Designed for utmost safety – Release-R™ displays one of the lowest entry profiles • Mounted on Veda PTCA catheter; which has tri folded / four folded balloon for safe crimping and optimal unfolding upon inflation • 90% of Sirolimus is released within 90-120 days

Relisys - Pristine+ : Everolimus Eluting Cobalt Chromium Coronary Stent System

Highlighting Features: • Pristine+ elutes Everolimus drug which is the most preferred drug by most of the interventional cardiologists • The basic stent platform for Pristine+ is L605 Cobalt Chromium stent • The strut thickness for Pristine+ is 60 μm • Pristine+ displays minimum recoil and excellent radial strength contributed by its unique open and closed cell stent design and strut locking mechanism • Pristine+ comes with rapid exchange Delivery System which enhances its efficacy • Uniform Everolimus Coating thickness and precise in Everolimus Drug Release Kinetics as 95 +/- 5% of Everolimus is released within 120 days • Hydrophilic Coated Stent Delivery System • Designed for utmost safety – Pristine+ displays one of the lowest entry profiles • Completely biodegradable, biocompatible polymer (PLGA carrier) – Loading dose density of 1.0μg/mm²

RELISYS - Bare Metal Stent System

Relisys - Cobal+C : Bare Metal Stent System

Highlighting Features: • Complete endothelialization is in 14 days • Lesser strut width hence results in minimal injury • Very low restenosis because of extremely smooth stent surface (mirror finish) • Cobal+C supports complete coverage of struts by neointima • Endothelial monolayer is fully functional – characterized by CD31 / PECAM, thrombomodulin expression • Thin struts 0.0025” (22% thinner than stainless – steel stents) • Hydrophilic Coated Stent Delivery System • Lower profile of 0.40 mm highly flexible • Higher radio – opacity which results in better biocompatibility

Relisys - M’Sure-Cr : Cobalt Chromium Coronary Stent

Highlighting Features: • M’Sure-Cr is made up of surgical grade Chromium Cobalt (L605), laser cut from seamless tubing in a serpentine pattern, which contains no Molybdenum and only 10% of Nickel • Nickel and Molybdenum contact allergies in patients with coronary in-stent restenosis (Lancet report1) • Ultra low strut thickness of 59µm with high radial strength of 1.1 bar & high degree of flexibility • During the bench testing, M’sure-Cr was found to have lowest force recorded for either tracking the stent in simulated model or pushing the stent through simulated vasculature

RELISYS - Transcatheter Heart Valves

TRICVALVE® - Transcatheter Bicaval Valves System

Transcatheter Bicaval Valves System is a boon for all those patients who cannot be operated through open-heart procedure because of any reason. TricValve® Transcatheter Bicaval Valves is a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux. The prostheses are implanted percutaneously into the superior and inferior vena cava without disturbing the native tricuspid valve. It is especially intended for use in patients at extreme risk or who are inoperable for open surgical therapy.

VIENNA AORTIC VALVE SE - Transcatheter Aortic Valve

The VIENNA AORTIC VALVE SE self-expandable transcatheter valve is designed to treat severe Aortic stenosis in patients at medium to high risk for open heart surgery. The minimal invasive heart valve replaces the native valve without the need for concomitant surgical removal and is placed via the femoral access. The new generation device comes fully pre-mounted with specially prepared bovine pericardium, thus reducing the time of the procedure and the preparation steps. SUPRA-ANNULAR VALVE DESIGN: Unsurpassed hemodynamics SELF-EXPANDING NITINOL FRAME: Provides the foundation for controlled delivery BOVINE PERICARDIAL TISSUE: Thin and strong for low profile delivery and durability ADVANCED SEALING: surface contact between a transcatheter aortic valve and the native anatomy is critical for effective sealing. The frame and consistent radial force of the VIENNA AORTIC VALVE SE valve enables contact at larger area.

RELISYS - PTCA Balloon Catheters

VEDA+R NC - Non Compliant Balloon Catheters

Highlighting Features: • High pressure capability and controlled expansion • Minimal growth and robust rated burst pressure • Combines advanced precision • Ensures optimum reliability and deliverability • Precise expansion

VEDA+R SC - Semi Compliant Balloon Catheters

Features: • Superior Crossability – Easy entry tip with a profile of 0.4 mm • Reliable Deliverability – Thin balloon wall thickness of 15 μm providing low profile • Hydrophilic Coating – Decreases the co-efficient of friction by 5 times and decreases the proximal push force by 50%

RELISYS - Diagnostic Catheters

Re’PACATH - Pulmonary Artery Catheter - RELISYS Medical Devices

Highlighting Features: • Re’PACATH allows reliable and continuous measurement of hemodynamic parameters, even in critically ill patients. • The balloon used in Re’PACATH is made of latex silicon that is non-toxic & non-pyrogenic. • Open port at the skiving portion facilitates easy drug delivery and easier withdrawal of the sample. • Infusion capacity is 1.5 CC. • Re’PACATH has markers at 10cm intervals, indicating insertion depth. • Re’PACATH 5Fr, 7Fr, 8Fr catheters are compatible with 6Fr, 8Fr, 9Fr sheaths respectively. • Re’PACATH has an effective working length of 110 cm. • Re’PACATH is available in 5 Fr., 7 Fr. & 8 Fr. Sizes. • Approved by DCGI.